The NEFA study: results at three years.
Martinez
Esteban
E
D000480:Alkynes; D000998:Antiviral Agents / Q000627:therapeutic use; D048588:Benzoxazines / Q000627:therapeutic use*; D003521:Cyclopropanes; D015224:Dideoxynucleosides / Q000627:therapeutic use*; D005500:Follow-Up Studies; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D053208:Kaplan-Meier Estimate; D019829:Nevirapine / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D013997:Time Factors; D000099227:Abacavir
D000480:Alkynes; D000998:Antiviral Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D015224:Dideoxynucleosides; D019829:Nevirapine; D000099227:Abacavir; C098320:efavirenz